Biologics
Biosimilars: Market Weaknesses and Strengths
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Biosimilars represent an emerging niche in the biopharmaceutical market, but how strong is their true potential?
Outsourcing
Biomanufacturing Innovation
Eric Langer, president of BioPlan Associates
Industry wants more innovation, but can suppliers meet customer needs?
Global Feature
As part of Pharmaceutical Technology’s special 35th Anniversary issue, we examine decades of change for the top pharmaceutical companies, project the pharmaceutical company of 2020, delve into the future of chemical API manufacturing, and take a retrospective and prospective look at pharmaceutical outsourcing.
Decades of Change for the Top Pharmaceutical Companies
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Tracking change from spinoffs of chemical companies to life-sciences powerhouses.
A Look into the Future: The Pharmaceutical Company of 2020
A Q&A with Carolyn Gauntlett, consultant with IMS Health
How will the pharmaceutical company of 2020 be different from the pharmaceutical company of 2010? A look at emerging business models and the factors influencing the direction of the global pharmaceutical industry.
What's Ahead in Chemical API Manufacturing
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Flow chemistry and microreactors offer an alternative to traditional batch manufacturing.
Advertisement:
Unlocking the Power of New Softgel Technology for Multiple API Formulations
Live Webcast: Thursday, July 26, 2012 at 11:00 am EDT
Register Free at  http://www.pharmtech.com/apiformulations
New Models in Contract Services
An industry roundtable examining how sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.
CSR and SUSTAINABILITY FORUM
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
The UN at the Sustainability Table
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Highlights of UN Conference on Sustainable Development, held in Rio de Janeiro, Brazil, last month and related industry initiatives.
| 
